[
  {
    "ts": null,
    "headline": "Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations",
    "summary": "HERCULES, Calif., July 28, 2025--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is retiring after a distinguished 26-year career with the company.",
    "url": "https://finnhub.io/api/news?id=9a8b3195e3f78fb7b4ef2b0015116bb88f3b56f74fd96f1491496361e2efedfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753733700,
      "headline": "Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations",
      "id": 136113466,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "HERCULES, Calif., July 28, 2025--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025. Mehta will lead Bio-Rad's global commercial strategy and execution, succeeding Mike Crowley, who is retiring after a distinguished 26-year career with the company.",
      "url": "https://finnhub.io/api/news?id=9a8b3195e3f78fb7b4ef2b0015116bb88f3b56f74fd96f1491496361e2efedfa"
    }
  },
  {
    "ts": null,
    "headline": "U.S.-EU Trade Deal: A One-Sided Affair",
    "summary": "U.S.-EU Trade Deal: A One-Sided Affair",
    "url": "https://finnhub.io/api/news?id=a74a5c206e62ebda0b52714775dcc6947289ba196441b0e3d7e814429523a36f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753724920,
      "headline": "U.S.-EU Trade Deal: A One-Sided Affair",
      "id": 136111772,
      "image": "",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a74a5c206e62ebda0b52714775dcc6947289ba196441b0e3d7e814429523a36f"
    }
  },
  {
    "ts": null,
    "headline": "EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say",
    "summary": "(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.  The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said.  Pharmaceuticals had historically been exempt from duties.",
    "url": "https://finnhub.io/api/news?id=b706c0126d225f7a2884a48c50867fd17472ef41e589d29bc4d4aabfe21bfbc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753724506,
      "headline": "EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say",
      "id": 136108212,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.  The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said.  Pharmaceuticals had historically been exempt from duties.",
      "url": "https://finnhub.io/api/news?id=b706c0126d225f7a2884a48c50867fd17472ef41e589d29bc4d4aabfe21bfbc8"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Inc. stock rises Monday, outperforms market",
    "summary": "Thermo Fisher Scientific Inc. stock rises Monday, outperforms market",
    "url": "https://finnhub.io/api/news?id=b1f76cb7dde38ef758a380d13ce8e28ea0172704632fa9f68b7eac8f6be6b888",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753720500,
      "headline": "Thermo Fisher Scientific Inc. stock rises Monday, outperforms market",
      "id": 136122462,
      "image": "",
      "related": "TMO",
      "source": "MarketWatch",
      "summary": "Thermo Fisher Scientific Inc. stock rises Monday, outperforms market",
      "url": "https://finnhub.io/api/news?id=b1f76cb7dde38ef758a380d13ce8e28ea0172704632fa9f68b7eac8f6be6b888"
    }
  },
  {
    "ts": null,
    "headline": "Revvity Q2: Headwinds From China And Customers, Buy On Weakness",
    "summary": "Revvity, Inc. targets high-growth markets like cell and gene therapies and precision medicine. Click for more on RVTY stock and why I'm bullish.",
    "url": "https://finnhub.io/api/news?id=8be1d52a37efd3a1ba4f4b715dc38606039f79fb6300fe9d29019a7cc1c8f01a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753714074,
      "headline": "Revvity Q2: Headwinds From China And Customers, Buy On Weakness",
      "id": 136107608,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1441662748/image_1441662748.jpg?io=getty-c-w1536",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "Revvity, Inc. targets high-growth markets like cell and gene therapies and precision medicine. Click for more on RVTY stock and why I'm bullish.",
      "url": "https://finnhub.io/api/news?id=8be1d52a37efd3a1ba4f4b715dc38606039f79fb6300fe9d29019a7cc1c8f01a"
    }
  },
  {
    "ts": null,
    "headline": "This is the Most Dangerous Week for Investors in 20 Years",
    "summary": "This might be the most critical week for investors in years. In fact, in over two decades of investing, and more than a decade as a professional analyst, I’ve never seen a single week with this many potentially market-moving headlines. Between earnings surprises, critical inflation and jobs data, a Federal Reserve decision, and a looming […]",
    "url": "https://finnhub.io/api/news?id=3315ac2616db1af65296df57dceb135172d67259603dcb2c9d1869e150750af9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753711725,
      "headline": "This is the Most Dangerous Week for Investors in 20 Years",
      "id": 136107935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "This might be the most critical week for investors in years. In fact, in over two decades of investing, and more than a decade as a professional analyst, I’ve never seen a single week with this many potentially market-moving headlines. Between earnings surprises, critical inflation and jobs data, a Federal Reserve decision, and a looming […]",
      "url": "https://finnhub.io/api/news?id=3315ac2616db1af65296df57dceb135172d67259603dcb2c9d1869e150750af9"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025",
    "summary": "CHICAGO, July 28, 2025--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill. The company debuts two new solutions, LabLink360™* and Thermo Scientific™ MAS™ Max quality controls, designed to support quality control assurance and streamline workflows in clinical lab",
    "url": "https://finnhub.io/api/news?id=3d842324889adcdec5a55ee94f9dc1381fc74df7787c727d0b78c690b77fcdfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753708680,
      "headline": "Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025",
      "id": 136108214,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "CHICAGO, July 28, 2025--Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill. The company debuts two new solutions, LabLink360™* and Thermo Scientific™ MAS™ Max quality controls, designed to support quality control assurance and streamline workflows in clinical lab",
      "url": "https://finnhub.io/api/news?id=3d842324889adcdec5a55ee94f9dc1381fc74df7787c727d0b78c690b77fcdfa"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's Gross Margin Falls on Product Transition and Trade Pressures",
    "summary": "Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.",
    "url": "https://finnhub.io/api/news?id=393091d9e30af250b63607354b1572cd8b400053567d7ab87e5a5bccf4facfa0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753705080,
      "headline": "ISRG's Gross Margin Falls on Product Transition and Trade Pressures",
      "id": 136108215,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's Q2 gross margin declines to 67.9% as product mix shifts, new facility costs and tariffs weigh on profitability.",
      "url": "https://finnhub.io/api/news?id=393091d9e30af250b63607354b1572cd8b400053567d7ab87e5a5bccf4facfa0"
    }
  },
  {
    "ts": null,
    "headline": "YourBio Health Unites Scientific Leaders to Make Pain-Free Blood Collection the Standard",
    "summary": "YourBio Health, the company behind TAP®, the industry's most advanced capillary blood collection technology, has officially launched its Scientific & Medical Advisory Board (SMAB) to accelerate its mission to modernize diagnostic testing for the 21st century.",
    "url": "https://finnhub.io/api/news?id=b7add4f8c637d5c1d4801b0bea738f35edbe10e25ca58521581df4f9bc738576",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753704840,
      "headline": "YourBio Health Unites Scientific Leaders to Make Pain-Free Blood Collection the Standard",
      "id": 136108216,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "YourBio Health, the company behind TAP®, the industry's most advanced capillary blood collection technology, has officially launched its Scientific & Medical Advisory Board (SMAB) to accelerate its mission to modernize diagnostic testing for the 21st century.",
      "url": "https://finnhub.io/api/news?id=b7add4f8c637d5c1d4801b0bea738f35edbe10e25ca58521581df4f9bc738576"
    }
  },
  {
    "ts": null,
    "headline": "The Highest-Quality Dividend Challengers By Quality Scores",
    "summary": "The Highest-Quality Dividend Challengers By Quality Scores",
    "url": "https://finnhub.io/api/news?id=cf2be551214592e2fab476897d927da6a91b6d21e9c2210f2c148ff19e36e80f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753693200,
      "headline": "The Highest-Quality Dividend Challengers By Quality Scores",
      "id": 136106454,
      "image": "",
      "related": "TMO",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=cf2be551214592e2fab476897d927da6a91b6d21e9c2210f2c148ff19e36e80f"
    }
  },
  {
    "ts": null,
    "headline": "Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450",
    "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the top low volatility healthcare stocks to buy now. On July 24, Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $490 from $450, keeping an Equal Weight rating on the shares. The analyst told investors in a research note […]",
    "url": "https://finnhub.io/api/news?id=3f88cfc75db64e2441850f99c42e473a7e767c821eea0ffc9d3fabc8b3b448c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753682883,
      "headline": "Barclays Lifts PT on Thermo Fisher Scientific (TMO) to $490 From $450",
      "id": 136108217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the top low volatility healthcare stocks to buy now. On July 24, Barclays analyst Luke Sergott raised the firm’s price target on Thermo Fisher Scientific Inc. (NYSE:TMO) to $490 from $450, keeping an Equal Weight rating on the shares. The analyst told investors in a research note […]",
      "url": "https://finnhub.io/api/news?id=3f88cfc75db64e2441850f99c42e473a7e767c821eea0ffc9d3fabc8b3b448c3"
    }
  },
  {
    "ts": null,
    "headline": "TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth",
    "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) but reduced its price target from $570 to $550. Citing current low levels and market mood, the firm believes an in-line second quarter […]",
    "url": "https://finnhub.io/api/news?id=d72e0f97b82353a405a838656f658de276f8bebc01214b8753de89d90445ad02",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753681318,
      "headline": "TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth",
      "id": 136108218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best low volatility stocks to buy according to analysts. On July 16, TD Cowen maintained its Buy rating on Thermo Fisher Scientific Inc. (NYSE:TMO) but reduced its price target from $570 to $550. Citing current low levels and market mood, the firm believes an in-line second quarter […]",
      "url": "https://finnhub.io/api/news?id=d72e0f97b82353a405a838656f658de276f8bebc01214b8753de89d90445ad02"
    }
  }
]